AxoGen AxoGen is a biotech company developing treatment options for the reconstruction and repair of peripheral nerve injuries. | ![]() Shanghai Rightongene Biotechnology Shanghai Rightongene Biotechnology (上海睿昂基因科技股份有限公司) is a company that manufactures and sells diagnostic products. | |
Founding Date | Founding Date 2002 | Founding Date 2012 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Alachua, US HQ Burleson, US | Locations CN HQ |
Employees | Employees 37133% increase | Employees 401 |
Valuation ($) | Valuation ($) 611.9 m | Valuation ($) 132.9 m |
Financial | ||
Revenue (est.) | Revenue (est.) $225.2m (FY, 2025) | Revenue (est.) ¥170.7m (FY, 2025) |
Cost of goods | Cost of goods $57.9m (FY, 2025) | Cost of goods ¥43.6m (FY, 2025) |
Gross profit | Gross profit $167.4m (FY, 2025) | Gross profit ¥130.3m (FY, 2025) |
Net income | Net income ($15.7m) (FY, 2025) | Net income (¥60.4m) (FY, 2025) |

Shanghai Rightongene Biotechnology (上海睿昂基因科技股份有限公司) is a company that manufactures and sells diagnostic products.
View company